Navigation Links
Triumphs and Hurdles for the New HPV Vaccine

Significant progress in women’s health was made this summer when the U.S. Food and Drug Administration (FDA) approved the first vaccine to prevent cervical cancer//. The vaccine was given the green light for use in younger women, as a way to protect against human papillomavirus (HPV), a sexually transmitted virus that causes cervical cancer.

“This is the first vaccine for a cancer ever developed,” said Phyllis Greenberger, president of the Society for Women’s Health Research and chair of the Partnership to Prevent Cervical Cancer, a coalition of American organizations and individuals dedicated to making the vaccine part of routine health care for all women in the United States. “Cervical cancer is the only cancer for which we know the cause and can provide a method of prevention that is successful in a vast majority of cases. This is a tremendous breakthrough that will save lives and reduce excess medical costs.”

The FDA has deemed the vaccine safe and effective for girls and women ages nine to 26 and studies are underway to determine the vaccine’s usefulness for women over the age of 26 and for boys and men. Other vaccines are also in development.

“The Advisory Committee on Immunization Practices (a federal panel of 15 experts) has recommended the HPV vaccine for females ages 11-12,” explains Janet Gilsdorf, M.D., professor and director of pediatric infectious diseases at the University of Michigan Medical Center in Ann Arbor. “Females ages 13-26 should also be vaccinated.”

The vaccine is specifically recommended for girls 11-12 because researchers discovered that the maximum benefit from the vaccine occurs when it is given prior to the first sexual experience. The vaccine does not work as well for those who have already been exposed to the virus, but most women will still benefit from getting the vaccine because they will be protected against other virus types contained in the vaccine.

There are many diff erent types of HPV, but only a select few can cause cervical cancer, Gilsdorf said. The HPV vaccine currently available may help guard against diseases that are caused by HPV Types 6, 11, 16, and 18. HPV Types 16 and 18 cause 70 percent of cervical cancer cases, and HPV Types 6 and 11 cause 90 percent of genital warts cases.

Roughly 80 percent of women will be infected by HPV by the age of 50, according to the Partnership to End Cervical Cancer.

Despite this significant advancement for women’s health, some issues remain surrounding the vaccine. “Access is always a concern for vaccines,” says Gilsdorf.

The HPV vaccine requires three doses and the list price for each dose is $120. Some insurance companies will pay for the vaccine and Vaccines for Children (VFC), a federal program administered by the Centers of Disease Control and Prevention, will pay for HPV vaccination for children 18 years of age and under that are Medicaid eligible, uninsured, American Indian or Alaska Native.

Underinsured children, whose health insurance benefit plan does not include vaccinations, can also receive VFC-funded vaccinations for free if they are served by a Federally Qualified Health Center or Rural Health Clinic. Parents who want to know if their children are VFC eligible should talk to their doctor or contact a local health clinic.

Follow-up and compliance with the three-part vaccine may become an issue for some women, especially college-aged women who may not return to the doctor to get the complete vaccination.

For some parents, condoning the administration of a sexually transmitted disease vaccine in their pre-pubescent daughters may cause concern. Some parents may have a tough time accepting or imagining the sexual activity of their daughters.

If a woman has HPV or even cervical cancer, she may not realize it. In general, there are few to no symptoms of cervical precancers or early cancers. It m ay take years for an infection with HPV to turn into cervical cancer, although some cases progress more quickly. Catching the disease in the early stages is imperative to a good prognosis. This is why it is so important for women to have this disease on their radar screen.

Pap tests are still recommended as a crucial part of cervical cancer screening. They have dramatically reduced the number of cervical cancer deaths in the United States. The American Cancer Society currently recommends an annual pap test for all women, three years after the start of vaginal intercourse, but not later than 21 years of age.

Source-Neswise
SRM
'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... NY (PRWEB) , ... January 19, 2017 , ... ... of Clinical Conductor CTMS, which provides a modern CTMS workflow designed to seamlessly ... management information has been condensed to a single page, maximizing usability and improving ...
(Date:1/19/2017)... ... January 19, 2017 , ... Students interested in video can get a jump ... winner will earn a $1,000 scholarship and have his or her video posted on ... deadline is May 31, with the winner announced on June 9. , The competition ...
(Date:1/19/2017)... ... January 19, 2017 , ... Workrite Ergonomics announced this week ... Tranquility privacy panel system was designed to deliver the ideal blend of acoustic ... and provide the visual privacy required to maintain concentration levels and increase productivity. ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Allegheny Health Network ... patients who seek access to the Network’s programs and services in the greater Pittsburgh ... specialty care appointments will be offered one for that same afternoon. , ...
(Date:1/19/2017)... ... January 19, 2017 , ... Rountree Brady Insurance Agency, a ... throughout eastern Georgia, is embarking on a charity effort to raise awareness and ... Americans every year than anything else, yet risk factors associated with heart disease ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... ViewRay, Inc. (Nasdaq: VRAY) announced today that the ... in Germany , has purchased a ... University Clinic Heidelberg as part of its initiative for ... will be headed by Medical Director and Professor Jürgen ... the German Cancer Research Center (DKFZ), the Heidelberg Heavy ...
(Date:1/19/2017)... , January 19, 2017 ... appears serious about reducing the FDA,s regulatory strictness ... in the medical drug industry, many of the ... new clinical trials and development of advanced drug ... ahead with recent developments include:  Moleculin Biotech, Inc., ...
(Date:1/19/2017)... ALAMEDA, Calif. , Jan. 18, 2017 /PRNewswire/ ... (MPI) solutions has entered into an agreement with ... for the Momentum MPI imaging system based on ... VivoQuant will be distributed as a complete MPI ... to enable quantitative nanoparticle or cell imaging in ...
Breaking Medicine Technology: